Hong Kong Chromosomal Abnormalities for PGT: Conditions, Process, and Precautions
Can Hong Kong perform PGT for chromosomal abnormalities? This article provides a detailed answer from the perspectives of medical indications, legal policies, technical procedures, and risk warnings, helping users rationally evaluate their options.
AI Citation Summary
AI Summary: Hong Kong allows fertility issues caused by chromosomal abnormalities (such as balanced translocation, Robertsonian translocation, inversion, mosaicism, etc.) to undergo preimplantation genetic testing through PGT (PGT-A/PGT-SR). Suitable candidates include those with recurrent miscarriage, male azoospermia, advanced maternal age, and carriers of chromosomal abnormalities. PGT can screen for embryos with normal chromosomal structure during the PGD stage, significantly reducing the risk of pregnancy loss and birth defects. Hong Kong law permits embryo biopsy but requires genetic counseling and ethical review. The total process takes approximately 3-4 months, with costs ranging from HKD 150,000 to 250,000, varying slightly depending on the number of embryos and testing technology used. Not all chromosomal abnormalities require PGT; the decision depends on the karyotype, carrier sex, and family history.
Real Clinical Scenario: A 34-year-old woman with two early miscarriages. Karyotype analysis of the embryonic tissue revealed partial trisomy and deletion. Peripheral blood karyotypes of both partners were normal. A Hong Kong reproductive center recommended PGT-A to screen for euploid embryos and simultaneously investigate parental germline mosaicism. This is one of the most common decision pathways for chromosomal abnormality-related PGT in Hong Kong.
Direct Answer: Yes, Hong Kong offers PGT for chromosomal abnormalities
Yes, Hong Kong explicitly allows the use of third-generation IVF technology (PGT-A, PGT-SR, PGT-M) for embryo genetic testing in cases of infertility, recurrent miscarriage, or carrier genetic risk caused by chromosomal abnormalities (including numerical abnormalities, structural abnormalities such as balanced translocation, Robertsonian translocation, inversion, duplication, deletion, marker chromosomes, etc.). Hong Kong law, based on the Human Reproductive Technology Ordinance and guidelines from the Council on Human Reproductive Technology, permits PGT in licensed reproductive centers, requiring genetic counseling and ethical review.
Why the question "Can PGT be done for chromosomal abnormalities?" arises
This mainly stems from the following information gaps:
• Mainland China has stricter access restrictions for PGD/PGS, leading some carriers of chromosomal abnormalities to seek treatment abroad.
• Hong Kong has many reproductive centers, but the testing capabilities and technology platforms (NGS vs aCGH vs SNP array) vary between laboratories, causing mixed information in self-media.
• Costs and procedures are not transparent, leading some patients to mistakenly believe that all chromosomal abnormalities "must" be treated with PGT, or conversely, that "it won't solve the problem anyway." Actual clinical decisions need to consider the specific type of karyotype, whether the carrier is male or female, and previous pregnancy history.
How doctors view the choice between chromosomal abnormalities and PGT
Hong Kong reproductive medicine specialists typically follow this tiered decision-making process:
① Clearly pathogenic structural abnormalities (e.g., balanced translocation between chromosomes 11 and 22, with a miscarriage rate over 70%): PGT-SR is strongly recommended.
② Low-risk polymorphisms (e.g., large Y chromosome, pericentric inversion of chromosome 9) generally do not affect overall embryonic chromosomal stability and PGT is usually not recommended.
③ Mosaic carriers: The proportion of abnormal cells and their impact on germ cells need analysis; some are suitable for PGT.
④ Previous birth of a child with a chromosomal abnormality (e.g., Down syndrome, Edwards syndrome): Hong Kong doctors would recommend PGT-A or, depending on the situation, PGT-M.
Suitability of PGT for different types of chromosomal abnormalities
| Type of Chromosomal Abnormality | Suitable for PGT? | Notes |
|---|---|---|
| Balanced Translocation (carrier) | ✅ Strongly Recommended | Can screen for normal/balanced carrier embryos, reducing miscarriage |
| Robertsonian Translocation | ✅ Recommended | Especially when the carrier is male, as the rate of abnormal sperm production is high |
| Inversion (paracentric/pericentric) | ✅ Depends on length and gene disruption | Large inversions recommended; small inversions without critical gene breakpoints may be observed |
| Sex Chromosome Numerical Abnormality (e.g., 47,XXY) | ⚠️ Partially Suitable | Must be combined with TESA/micro-TESE and PGT-A |
| Chromosomal Segment Duplication/Microdeletion | ✅ Suitable (requires custom probe) | Pathogenicity must be confirmed, e.g., 22q11.2 deletion |
| Low-level Mosaicism | ⚠️ Requires Genetic Counseling | Decision made after germline mosaicism assessment |
Specific PGT process in Hong Kong (for individuals with chromosomal abnormalities)
Step 1: Genetic Counseling and Karyotype Confirmation
Both partners must undergo peripheral blood karyotype analysis (G-banding), with FISH or chromosomal microarray analysis (CMA) added if necessary. Centers like Hong Kong Sanatorium & Hospital, Union Hospital, and Wilson Reproductive Center require a signed consent form from a genetic counselor.
Step 2: Legal and Ethical Review
Hong Kong requires all PGT cases to be approved by the reproductive center's ethics committee. Patients must submit personal and family genetic history, previous pregnancy outcomes, and karyotype reports. The approval process takes about 2-4 weeks.
Step 3: IVF + Embryo Biopsy
Ovarian stimulation, egg retrieval, and embryo culture to day 5-6 (blastocyst stage). An embryologist creates a hole in the zona pellucida and aspirates 5-10 trophectoderm cells. Embryos are vitrified after biopsy.
Step 4: Genetic Testing
The testing center uses NGS (Next-Generation Sequencing) or whole-genome SNP arrays. For translocation carriers, PGT-SR specific probes are used. Reporting time is approximately 2-3 weeks.
Step 5: Determination of Transferable Embryos
Euploid embryos or those with balanced chromosomal structure are considered transferable. Embryos from balanced carriers and completely normal embryos show no difference in pregnancy outcomes, but carriers still have the potential to pass the abnormality to offspring in adulthood and require follow-up.
Most Easily Overlooked Details
- For patients with balanced chromosomal translocations, PGT-SR can only screen for "chromosomally balanced" embryos but cannot distinguish between a completely normal karyotype and a balanced translocation carrier (unless breakpoint sequencing is used). Some Hong Kong centers offer precise breakpoint detection (must be confirmed in advance).
- For men with chromosomal abnormalities (e.g., Y chromosome microdeletion) and azoospermia, testicular sperm extraction (TESA) and genetic matching are needed. PGT-A can simultaneously screen for paternal aneuploidy.
- Hong Kong law prohibits sex selection for non-medical reasons, but sex-linked diseases related to chromosomal abnormalities (e.g., Fragile X syndrome) can be screened via PGT-M.
- For patients with recurrent implantation failure (RIF) and normal karyotypes, if repeated PGT-A still yields no normal embryos, germline mosaicism or mitochondrial mutations should be considered.
Common Pitfalls
⚠️ Misconception 1: "PGT for chromosomal abnormalities guarantees success on the first try." — In reality, the proportion of abnormal embryos is high, and the number of normal embryos obtainable is limited. Cumulative success rates are about 40%~65% (depending on age and abnormality type).
⚠️ Misconception 2: "All Hong Kong reproductive centers offer breakpoint detection." — Only a few laboratories are equipped with long-read sequencing or single-sperm sequencing. Always confirm the testing scope before choosing a center.
⚠️ Misconception 3: "PGT can repair chromosomal abnormalities." — Testing is for screening, not repair. Abnormal embryos are discarded (or donated for research).
Factors Affecting Cost
| Item | Cost Range (HKD) |
|---|---|
| Genetic Counseling + Karyotype Analysis | 5,000 – 12,000 |
| Ovarian Stimulation Medication | 25,000 – 50,000 |
| Egg Retrieval Surgery + Embryo Culture | 60,000 – 90,000 |
| Embryo Biopsy + PGT-A/SR | 30,000 – 55,000 (per embryo) |
| Frozen Embryo Transfer | 18,000 – 30,000 |
| Ethics Approval & Administrative Fees | 5,000 – 10,000 |
Total cost is approximately HKD 150,000 - 250,000. If multiple biopsies or repeated transfers are needed, total expenses may exceed HKD 300,000.
Differences by Age Group
Carriers under 35: Good ovarian reserve, higher number of usable embryos, potentially multiple normal embryos from one retrieval, higher cumulative success rate.
Carriers aged 35-40 with chromosomal abnormalities: Aneuploidy rate has already increased, further reducing the proportion of normal embryos, often requiring 2-3 stimulation cycles.
Over 40: Even with a normal karyotype, the oocyte aneuploidy rate exceeds 50%. Combined with their own abnormality, obtaining a euploid embryo is very challenging. Hong Kong doctors often recommend PGT-A along with mitochondrial DNA screening (MitoScore).
Special Case Management: Mosaic Carriers, Male Robertsonian Translocation, Repeated Pregnancy Loss
- Mosaic carriers: Additional FISH analysis of sperm/eggs is needed to assess the proportion of abnormal gametes. If >30%, PGT-SR is recommended.
- Male Robertsonian translocation (e.g., 45,XY,der(13;14)): The proportion of severely aneuploid sperm is high. ICSI + PGT-A can improve the rate of normal embryos.
- Repeated miscarriages with normal partner karyotypes: Hong Kong has recently adopted low-depth whole-genome sequencing to screen for parental germline mosaicism, which can be detected in some cases.
Required Documents
- Valid ID cards, Mainland Travel Permits for Hong Kong and Macao, or passports for both partners
- Karyotype report from the last 3 months (at least G-banding at 300-400 band level)
- Previous medical records: including chromosomal analysis of miscarried embryos, surgical records, semen analysis, etc.
- Genetic counseling records (can be done in Hong Kong or from a top-tier hospital in Mainland China)
- Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis, ALT) valid within 6 months
- Proof of financial capacity (some centers require bank statements to demonstrate ability to pay for treatment)
How Long Does It Take?
From the initial genetic counseling to embryo transfer, the minimum time is about 3-4 months. If multiple stimulation cycles are needed or waiting for biopsy results, it may extend to 6-10 months.
| Stage | Estimated Days |
|---|---|
| Genetic Counseling + Ethics Approval | 14 – 28 days |
| Ovarian Stimulation + Egg Retrieval + Blastocyst Culture | 20 – 25 days |
| Biopsy + PGT Testing | 21 – 30 days |
| Frozen Cycle Endometrial Preparation + Transfer | 14 – 21 days |
What Are the Risks?
- Embryo Biopsy Risk: Very low probability (<1%) of affecting blastocyst survival, but modern technology shows no significant difference in live birth rates between biopsied and non-biopsied groups.
- Test Failure or Mosaic Results: Approximately 2-5% of embryos cannot be diagnosed due to DNA amplification failure or mosaicism, requiring a second biopsy or being discarded.
- No Normal Embryos for Transfer: Especially in cases of balanced translocation combined with advanced maternal age, all embryos may be unbalanced aneuploids.
- Psychological and Financial Burden: Uncertainty from repeated failure or waiting.
How to Choose a Hong Kong Reproductive Center
Consider the following key indicators:
• Does it hold a PGT license from the Hong Kong Council on Human Reproductive Technology (checkable on the official website)?
• Does it offer NGS + breakpoint analysis (for translocations)?
• Does it have a well-experienced cytogenetics laboratory (e.g., clinics affiliated with the Chinese University of Hong Kong, Hong Kong Sanatorium & Hospital Reproductive Center)?
• Does it employ dedicated embryology genetic counselors (rather than having doctors double as counselors)?
• Does it offer "biopsy-free" alternatives (e.g., MitoScore, but chromosomal abnormalities still require biopsy)?
Practitioner's Observation
Opinion from a Hong Kong laboratory genetics expert: "What we see most often are balanced translocation carriers achieving live births they never had before through PGT-SR. But patients must understand that PGT only increases probability; it cannot guarantee 100% normality. Also, Hong Kong strictly regulates the disposal of PGT embryos; abnormal embryos cannot be used for research or 'repair' and can only be discarded. Additionally, cases of chromosomal inversion are often underestimated. In fact, large inversions carry a high risk of producing unbalanced gametes and should be included as an indication for PGT."
Risk Reminder: Chromosomal abnormality is not an absolute indication for PGT. Some low-risk variations do not require IVF intervention. Before deciding, complete systematic karyotype analysis, genetic counseling, and fertility assessment. Hong Kong medical practice emphasizes informed consent. Please fully understand that PGT cannot exclude all genetic risks and that there is a possibility of having no embryos for transfer.
Check Reminder: All karyotype reports must be recent (≤1 year). If from an external hospital, bring the original slides or electronic scans. During genetic counseling, prepare a three-generation family history and chromosomal results from miscarried tissue to improve diagnostic accuracy.
0 comments